Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer: Joint effect with vitamin D?

Calypse B. Agborsangaya, Tuula Lehtinen, Adetunji T. Toriola, Eero Pukkala, Helja Marja Surcel, Rosamaria Tedeschi, Matti Lehtinen

Research output: Contribution to journalArticle

Abstract

Background: Few studies have evaluated the role of the ubiquitous Epstein-Barr virus (EBV) infection, together with levels of the immunomodulator, vitamin D, in different breast cancer entities. We studied, prospectively, the association of EBV and vitamin D status with the risk of pregnancy-associated breast cancer (PABC), breast cancer diagnosed during pregnancy or 1 year post-partum, using a nested case-control study. Methods: Serum vitamin D and antibodies to EBV were measured for 108 PABC cases of the Finnish Maternity Cohort, and 208 controls matched for date of birth, date of sampling and parity. The joint effect of vitamin D and EBV on the risk of PABC was evaluated. Results: EBV seropositivity was generally not associated with the risk of PABC. Among individuals with sufficient (≥75 nmol/l) levels of vitamin D, we, however, found similar increased risk estimates for PABC associated with serum immunoglobulin G (IgG) antibodies to EBV early antigens [odds ratio (OR) = 7.7, 95% (confidence interval) CI 1.4-42.3] and the viral reactivator protein, ZEBRA (OR = 7.8, 95% CI 1.1-61.2). Conclusion: Immunological markers of EBV reactivation status among individuals with sufficient vitamin D levels were consistently associated with increased risk of the disease. This suggests that EBV reactivation may be an indicator of the progression of breast cancer occurring soon after pregnancy, while the virus probably is not the aetiological agent.

Original languageEnglish
Pages (from-to)116-120
Number of pages5
JournalEuropean Journal of Cancer
Volume47
Issue number1
DOIs
Publication statusPublished - Jan 2011

Fingerprint

Epstein-Barr Virus Infections
Vitamin D
Breast Neoplasms
Human Herpesvirus 4
Pregnancy
Odds Ratio
Antibodies
Immunologic Factors
Viral Proteins
Parity
Serum
Case-Control Studies
Immunoglobulin G
Parturition
Confidence Intervals
Viruses

Keywords

  • Breast cancer
  • Epstein-Barr virus
  • Nested case-control study
  • Pregnancy-associated breast cancer
  • Vitamin D

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer : Joint effect with vitamin D? / Agborsangaya, Calypse B.; Lehtinen, Tuula; Toriola, Adetunji T.; Pukkala, Eero; Surcel, Helja Marja; Tedeschi, Rosamaria; Lehtinen, Matti.

In: European Journal of Cancer, Vol. 47, No. 1, 01.2011, p. 116-120.

Research output: Contribution to journalArticle

Agborsangaya, Calypse B. ; Lehtinen, Tuula ; Toriola, Adetunji T. ; Pukkala, Eero ; Surcel, Helja Marja ; Tedeschi, Rosamaria ; Lehtinen, Matti. / Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer : Joint effect with vitamin D?. In: European Journal of Cancer. 2011 ; Vol. 47, No. 1. pp. 116-120.
@article{127fa3ecc5b5492d91d4874a9db9ece9,
title = "Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer: Joint effect with vitamin D?",
abstract = "Background: Few studies have evaluated the role of the ubiquitous Epstein-Barr virus (EBV) infection, together with levels of the immunomodulator, vitamin D, in different breast cancer entities. We studied, prospectively, the association of EBV and vitamin D status with the risk of pregnancy-associated breast cancer (PABC), breast cancer diagnosed during pregnancy or 1 year post-partum, using a nested case-control study. Methods: Serum vitamin D and antibodies to EBV were measured for 108 PABC cases of the Finnish Maternity Cohort, and 208 controls matched for date of birth, date of sampling and parity. The joint effect of vitamin D and EBV on the risk of PABC was evaluated. Results: EBV seropositivity was generally not associated with the risk of PABC. Among individuals with sufficient (≥75 nmol/l) levels of vitamin D, we, however, found similar increased risk estimates for PABC associated with serum immunoglobulin G (IgG) antibodies to EBV early antigens [odds ratio (OR) = 7.7, 95{\%} (confidence interval) CI 1.4-42.3] and the viral reactivator protein, ZEBRA (OR = 7.8, 95{\%} CI 1.1-61.2). Conclusion: Immunological markers of EBV reactivation status among individuals with sufficient vitamin D levels were consistently associated with increased risk of the disease. This suggests that EBV reactivation may be an indicator of the progression of breast cancer occurring soon after pregnancy, while the virus probably is not the aetiological agent.",
keywords = "Breast cancer, Epstein-Barr virus, Nested case-control study, Pregnancy-associated breast cancer, Vitamin D",
author = "Agborsangaya, {Calypse B.} and Tuula Lehtinen and Toriola, {Adetunji T.} and Eero Pukkala and Surcel, {Helja Marja} and Rosamaria Tedeschi and Matti Lehtinen",
year = "2011",
month = "1",
doi = "10.1016/j.ejca.2010.07.006",
language = "English",
volume = "47",
pages = "116--120",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "1",

}

TY - JOUR

T1 - Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer

T2 - Joint effect with vitamin D?

AU - Agborsangaya, Calypse B.

AU - Lehtinen, Tuula

AU - Toriola, Adetunji T.

AU - Pukkala, Eero

AU - Surcel, Helja Marja

AU - Tedeschi, Rosamaria

AU - Lehtinen, Matti

PY - 2011/1

Y1 - 2011/1

N2 - Background: Few studies have evaluated the role of the ubiquitous Epstein-Barr virus (EBV) infection, together with levels of the immunomodulator, vitamin D, in different breast cancer entities. We studied, prospectively, the association of EBV and vitamin D status with the risk of pregnancy-associated breast cancer (PABC), breast cancer diagnosed during pregnancy or 1 year post-partum, using a nested case-control study. Methods: Serum vitamin D and antibodies to EBV were measured for 108 PABC cases of the Finnish Maternity Cohort, and 208 controls matched for date of birth, date of sampling and parity. The joint effect of vitamin D and EBV on the risk of PABC was evaluated. Results: EBV seropositivity was generally not associated with the risk of PABC. Among individuals with sufficient (≥75 nmol/l) levels of vitamin D, we, however, found similar increased risk estimates for PABC associated with serum immunoglobulin G (IgG) antibodies to EBV early antigens [odds ratio (OR) = 7.7, 95% (confidence interval) CI 1.4-42.3] and the viral reactivator protein, ZEBRA (OR = 7.8, 95% CI 1.1-61.2). Conclusion: Immunological markers of EBV reactivation status among individuals with sufficient vitamin D levels were consistently associated with increased risk of the disease. This suggests that EBV reactivation may be an indicator of the progression of breast cancer occurring soon after pregnancy, while the virus probably is not the aetiological agent.

AB - Background: Few studies have evaluated the role of the ubiquitous Epstein-Barr virus (EBV) infection, together with levels of the immunomodulator, vitamin D, in different breast cancer entities. We studied, prospectively, the association of EBV and vitamin D status with the risk of pregnancy-associated breast cancer (PABC), breast cancer diagnosed during pregnancy or 1 year post-partum, using a nested case-control study. Methods: Serum vitamin D and antibodies to EBV were measured for 108 PABC cases of the Finnish Maternity Cohort, and 208 controls matched for date of birth, date of sampling and parity. The joint effect of vitamin D and EBV on the risk of PABC was evaluated. Results: EBV seropositivity was generally not associated with the risk of PABC. Among individuals with sufficient (≥75 nmol/l) levels of vitamin D, we, however, found similar increased risk estimates for PABC associated with serum immunoglobulin G (IgG) antibodies to EBV early antigens [odds ratio (OR) = 7.7, 95% (confidence interval) CI 1.4-42.3] and the viral reactivator protein, ZEBRA (OR = 7.8, 95% CI 1.1-61.2). Conclusion: Immunological markers of EBV reactivation status among individuals with sufficient vitamin D levels were consistently associated with increased risk of the disease. This suggests that EBV reactivation may be an indicator of the progression of breast cancer occurring soon after pregnancy, while the virus probably is not the aetiological agent.

KW - Breast cancer

KW - Epstein-Barr virus

KW - Nested case-control study

KW - Pregnancy-associated breast cancer

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=78650413864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650413864&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2010.07.006

DO - 10.1016/j.ejca.2010.07.006

M3 - Article

C2 - 20691583

AN - SCOPUS:78650413864

VL - 47

SP - 116

EP - 120

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 1

ER -